Literature DB >> 24926806

Cardiovascular disease and hepatitis C virus infection: an irrelevant statement or a hot relationship?

Vasiliki Katsi1, Ioannis Felekos, Stamatios Skevofilax, Constantina Aggeli, Dimitris Tousoulis, Christodoulos Stefanadis, Ioannis Kallikazaros.   

Abstract

Hepatitis C virus (HCV) is well known for being the leading cause of hepatocellular carcinoma and cirrhosis, contributing to a devastating array of metabolic dysfunctions associated with hepatic failure. However, the cardiac manifestations of HCV and chronic hepatitis C (CHC) are being explored, thus illuminating the connection between HCV infection and cardiac disease. Although not all studies agree, the evidence in favor of CHC promoting major risk factors for cardiovascular disease such as hypertension, insulin resistance, diabetes mellitus, and atherosclerosis is compelling. Similarly, properly warranted attention is being guided towards CHC as an independent risk factor for the development of atherosclerotic heart disease and cardiomyopathy. This review provides a synopsis on the relationship between (HCV) infection and cardiac disease, emphasizing on some of the key possible mechanisms and population derived data.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24926806     DOI: 10.1097/CRD.0000000000000031

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  6 in total

1.  Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Antonio Russo; Mariantonietta Pisaturo; Clarissa Camaioni; Roberta Astorri; Nicola Coppola
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy.

Authors:  A Rivero-Juarez; L F Lopez-Cortes; M Castaño; D Merino; M Marquez; M Mancebo; F Cuenca-Lopez; P Jimenez-Aguilar; I Lopez-Montesinos; S Lopez-Cardenas; A Collado; M A Lopez-Ruz; M Omar; F Tellez; X Perez-Stachowski; J Hernandez-Quero; J A Girón-Gonzalez; E Fernandez-Fuertes; A Rivero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-27       Impact factor: 3.267

Review 3.  Cardiovascular Involvement in Chronic Hepatitis C Virus Infections - Insight from Novel Antiviral Therapies.

Authors:  Wolfgang Poller; Arash Haghikia; Mario Kasner; Ziya Kaya; Udo Bavendiek; Heiner Wedemeier; Hans-Jörg Epple; Carsten Skurk; Ulf Landmesser
Journal:  J Clin Transl Hepatol       Date:  2018-01-26

4.  Impact of chronic hepatitis on cardiovascular events among type 2 diabetes patients in Taiwan pay-for-performance program.

Authors:  Chih-Cheng Hsu; Wen-Chen Tsai; Yi-Jing Sheen; Pei-Tseng Kung; Li-Ting Chiu
Journal:  Sci Rep       Date:  2022-07-09       Impact factor: 4.996

5.  The Hypertension of Hemophilia Is Not Explained by the Usual Cardiovascular Risk Factors: Results of a Cohort Study.

Authors:  Richard F W Barnes; Thomas J Cramer; Afrah S Sait; Rebecca Kruse-Jarres; Doris V K Quon; Annette von Drygalski
Journal:  Int J Hypertens       Date:  2016-11-14       Impact factor: 2.420

6.  Ethnic differences in infectious burden and the association with metabolic risk factors for cardiovascular disease: a cross-sectional analysis.

Authors:  Lara Hartog; Martijn S van Rooijen; Joanne Ujčič-Voortman; Maria Prins; Irene G M van Valkengoed
Journal:  BMC Public Health       Date:  2018-02-22       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.